key: cord-0915700-rs6tqlja authors: Finsterer, Josef; Stollberger, Claudia title: Update on the neurology of COVID‐19 date: 2020-06-02 journal: J Med Virol DOI: 10.1002/jmv.26000 sha: a82d57cbf450d549cbc0879834d6884aedfc64e6 doc_id: 915700 cord_uid: rs6tqlja Though infection with the SARS-CoV2 virus predominantly manifests in the lung as an interstitial pneumonia ("ground glass opacities"), there is increasing evidence that the virus invades all compartments of the body, particularly the eyes, heart, skin, kidneys, and the central nervous system(CNS).1 This article is protected by copyright. All rights reserved. To the Editor, Though infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus predominantly manifests in the lung as an interstitial pneumonia ("ground glass opacities"), there is increasing evidence that the virus invades all compartments of the body, particularly the eyes, heart, skin, kidneys, and the central nervous system (CNS). 1 In a recent systematic review, six studies were included, which reported on the presence of neurological manifestations in patients with COVID-19. 2 These include dizziness, impaired consciousness, confusion, headache, ataxia, seizures, ischemic stroke, sinus venous thrombosis, and cerebral hemorrhage. 2 The study did not mention encephalitis, meningitis, neuritis, or radiculitis, manifestations which are most conceivable in the context of this viral infection. A more intense search for neurological involvement, however, revealed that CNS/PNS are indeed much more severely involved than so far anticipated. There is now clear evidence that SARS-CoV2 can cause meningitis and encephalitis. 3, 4 The first case of meningoencephalitis was reported in a 24 years male who experienced fever and generalized fatigue, took laninamivir and antiypyretics, but was found unconscious 9 days later and developed seizures during admission. 3 Specific SARS-CoV2 RNA was found in the cerebrospinal fluid (CSF) but not in the naso-pharyngeal swab. 3 Cerebral magnetic resonance imaging revealed hyperintensity along the wall of the right lateral ventricle and in the right mesial temporal lobe and hippocampus, suggesting meningitis. 3 1 Yang et al, 6 Li et al, 7 Reduced alertness RCS Mao et al, 1 Wang et al, 10 Chen et al, 11 and Yin et al 12 Guillain-Barre syndrome Case report Virani et al, 13 Sedaghat et al, 14 Toscano et al, 15 In a Chinese study of 214 infected patients, 36.4% had neurological manifestations. 1 In this study, neurological manifestations, in addition to the ones mentioned above, included hyposmia, hypogeusia, visual impairment, and neuralgia. 1 Hyposmia/hypogeusia was reported in 5.1% respectively, 5.6% of the infected patients but has been repeatedly observed since this first description. 16 Hypogeusia/ hyposmia may particularly occur in the early stages of a COVID-19 infection, most frequently before onset of pulmonary manifestations. Though a CNS/PNS cause cannot be definitively excluded, hyposmia/ hypogeusia may be rather attributable to a direct contact of the virus with taste buds or olfactory receptors than meningitis or neuritis. 20 Other indications for affection of the PNS come from studies which reported neuralgia and myalgia in SARS-CoV2 infected patients ( Ischemic stroke is regarded secondary as there is currently no indication for cerebral vasculitis or acute macroangiopathy of the intra-or extracerebral arteries. COVID-19 becomes also a challenge for the neurologist. Neurologic manifestations of hospitalized patients with coronavirus disease Central nervous system manifestations of COVID-19: a systematic review A first case of meningitis/encephalitis associated with SARS-coronavirus-2 Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles New-onset acute symptomatic seizure and risk factors in corona virus disease 2019: a retrospective multicenter study Analysis of 92 deceased patients with COVID-19 Acute Cerebrovascular Disease Following COVID-19: a Single Center, Retrospective, Observational Study COVID-19 presenting as stroke Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals Potential neurological symptoms of COVID-19 Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019 Guillain-Barré Syndrome associated with SARS-CoV-2 infection Guillain Barre syndrome associated with COVID-19 infection: a case report Guillain-Barré Syndrome Associated with SARS-CoV-2 Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas 2020. pii: jjaa058 Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients Comment on "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Central nervous system involvement by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2)